Benign Prostate Hypertrophy(BPH)
13
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
15%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Holmium Laser Enucleation Of the Prostate Versus Water Vapor Therapy Of The Prostate on Sexual Function and Ejaculation
Stone and Laser Therapies Post-Market Study (SALT)
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
Early Versus Delayed Trial Without Catheter in Men With Acute Urinary Retention.
Efficacy of Prostatic Arteries Embolization Using SQUIDPERI
Evaluation of the Application Effect of a Surgical Navigation System in HoLEP Surgery
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
Transurethral Focal Laser Ablation Versus Transurethral Prostatectomy For Management Of Benign Prostatic Obstruction
Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia
Investigating the Adjunctive Use of Mirabegron in the Early Post-Rezum Procedure Period
Safety and Efficacy of MILEP Versus Standard EEP
Investigation of the Diagnostic Role of miRNAs in PCa and BPH